ReviewJournal of nanobiotechnology2025

Nanomedicine targeting the PD-1/PD-L1 axis in autoimmune diseases: breaking conventional barriers to restore immune tolerance.

Gang Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.